// App-Quantinova.ai

NIMG-22 : PREDICTION OF GLIOBLASTOMA CELLULAR INFILTRATION AND RECURRENCE USING MACHINE LEARNING AND MULTI-PARAMETRIC MRI ANALYSIS: RESULTS FROM THE MULTI-INSTITUTIONAL RESPOND CONSORTIUM

Researchers

Presenter

  • Hamed Akbari

Principal Investigators

  • Jose A Garcia

  • Anahita Fathi Kazerooni

  • Chiharu Sako

  • Spyridon Bakas

  • Gaurav Shukla

  • Stephen J Bagley

  • Sung Soo Ahn

  • Murat AK

  • Gregory S Alexander

  • Ayesha S Ali

  • Ujjwal Baid

  • Chaitra Bavde

  • Steven Brem

  • Jaume Capellades

  • Jong Hee Chang

  • Yoon Seong Choi

  • Adam P Dicker

  • Hassan Fathallah-Shaykh

  • Adam E Flanders

  • Brent D Griffith

  • Pamela LaMontagne

  • Matthew Lee

  • Seung-Koo Lee

  • Spencer Liem

  • Joseph Lombardo

  • Abhishek Mahajan

  • Mikhail Milchenko

  • Arash Nazeri

  • Josep Puig

  • Andrew Sloan

  • William Taylor

  • Vachan Vadmal

  • Kristin Waite

  • MacLean Nasrallah

  • Michel Bilello

  • Robert A Lustig

  • Carmen Balana

  • Thomas C Booth

  • Santiago Cepeda

  • Laila Poisson

  • Rivka R Colen

  • Daniel S Marcus

  • Joshua Palmer

  • Rajan Jain

  • Wenyin Shi

  • Donald M O’Rourke

  • Jill Barnholtz-Sloan

  • Christos Davatzikos

Medical Centers

  • Consorci Mar Parc de Salut, Barcelona, Spain

  • University of Pennsylvania, Philadelphia, PA, USA

  • Case Western Reserve University and University Hospitals of Cleveland, Cleveland, OH, USA

  • Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA

  • University of Pittsburgh, Pittsburgh, PA, USA

  • Tata Memorial Centre and Homi Bhabha National Institute, Mumbai, India

  • Thomas Jefferson University, Philadelphia, PA, USA

  • School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK

  • Cleveland Center for Health Outcomes (CCHOR), Cleveland, OH, USA

  • Department of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea

  • University of Maryland, Baltimore, MD, USA

  • The James Cancer Hospital at the Ohio State University Wexner Medical Center, Columbus, OH, USA

  • The University of Alabama at Birmingham, Birmingham, AL, USA

  • Department of Radiology, Yonsei University College of Medicine, Seoul, Republic of Korea

  • Department of Neurosurgery, University Hospital Río Hortega, Valladolid, Spain

  • Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA

  • New York University Langone Health, New York, NY, USA

  • Washington University in St. Louis, Saint Louis, WA, USA

  • Medical Oncology Department, Catalan Institute of Oncology (ICO), Badalona, Spain

  • The Ohio State University Wexner Medical Center, OH, USA

  • Henry Ford Health System, Detroit, MI, USA

  • Center for Biomedical Informatics and Information Technology and Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA

  • Research Unit (IDIR) Image Diagnosis Institute, Badalona, Spain

  • Wayne State University, Detroit, MI, USA

  • National Cancer Institute, Cleveland, OH, USA

  • UH Cleveland Medical Center & Seidman Cancer Center, Cleveland, OH, USA

Locations

  • Spain

  • United Kingdom

  • United States

  • Republic of South Korea

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

Biomarkers

  • Apparent diffusion coefficient

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved